Bone Safety of Dual-Release Hydrocortisone in Patients With Hypopituitarism

Endocrine. 2018 Jun;60(3):528-531. doi: 10.1007/s12020-017-1512-1. Epub 2018 Jan 8.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Humans
  • Hydrocortisone / adverse effects*
  • Hydrocortisone / therapeutic use
  • Hypopituitarism / drug therapy*
  • Male
  • Middle Aged
  • Osteoporosis / chemically induced*

Substances

  • Hydrocortisone